Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Peptides ; 49: 74-80, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24028792

ABSTRACT

We previously showed that short-term hypo- and hyperthyroidism induce changes in neuropeptide glutamic-acid-isoleucine-amide (NEI) concentrations in discrete brain areas in male rats. To investigate the possible effects of hypo- and hyperthyroidism on NEI concentrations mainly in hypothalamic areas related to reproduction and behavior, female rats were sacrificed at different days of the estrous cycle. Circulating luteinizing hormone (LH), estradiol and progesterone concentrations were measured in control, hypothyroid (hypoT, treated with PTU during 7-9 days) and hyperthyroid (hyperT, l-T4 during 4-7 days) animals. Both treatments blunted the LH surge. Hypo- and hyperthyroidism increased estradiol concentrations during proestrus afternoon (P-PM), although hypoT rats showed lower values compared to control during proestrus morning (P-AM). Progesterone levels were higher in all groups at P-PM and in the hyperT during diestrus morning (D2). NEI concentrations were lower in hypoT rats during the estrous cycle except in estrus (E) in the peduncular part of the lateral hypothalamus (PLH). They were also reduced by both treatments in the perifornical part of the lateral hypothalamus (PeFLH) during P-PM. Hypothyroidism led to higher NEI concentrations during P-PM in the organum vasculosum of the lamina terminalis and anteroventral periventricular nucleus (OVLT+AVPV). The present results indicate that NEI concentration is regulated in a complex manner by hypo- and hyperthyroidism in the different areas studied, suggesting a correlation between NEI values and the variations of gonadal steroid levels during estrous cycle. These changes could be, in part, responsible for the alterations observed in the hypothalamic-pituitary-gonadal axis in these pathologies.


Subject(s)
Brain/metabolism , Estrus , Hyperthyroidism/physiopathology , Hypothyroidism/physiopathology , Oligopeptides/metabolism , Reproduction , Animals , Estradiol/blood , Female , Luteinizing Hormone/blood , Progesterone/blood , Rats , Rats, Wistar , Thyrotropin/blood
2.
Peptides ; 32(6): 1249-54, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21530599

ABSTRACT

To date, there has been only one in vitro study of the relationship between neuropeptide EI (NEI) and the hypothalamic-pituitary-thyroid (HPT) axis. To investigate the possible relationship between NEI and the HPT axis, we developed a rat model of hypothyroidism and hyperthyroidism that allows us to determine whether NEI content is altered in selected brain areas after treatment, as well as whether such alterations are related to the time of day. Hypothyroidism and hyperthyroidism, induced in male rats, with 6-propyl-1-thiouracil and l-thyroxine, respectively, were confirmed by determination of triiodothyronine, total thyroxine, and thyrotropin levels. All groups were studied at the morning and the afternoon. In rats with hypothyroidism, NEI concentration, evaluated on postinduction days 7 and 24, was unchanged or slightly elevated on day 7 but was decreased on day 24. In rats with hyperthyroidism, NEI content, which was evaluated after 4 days of l-thyroxine administration, was slightly elevated, principally in the preoptic area in the morning and in the median eminence-arcuate nucleus and pineal gland in the afternoon, the morning and afternoon NEI contents being similar in the controls. These results provide the bases to pursue the study of the interaction between NEI and the HPT axis.


Subject(s)
Brain/metabolism , Hyperthyroidism/metabolism , Hypothyroidism/metabolism , Median Eminence/metabolism , Oligopeptides/biosynthesis , Pituitary Gland/metabolism , Thyroid Gland/metabolism , Animals , Brain/drug effects , Hyperthyroidism/chemically induced , Hyperthyroidism/physiopathology , Hypothyroidism/chemically induced , Hypothyroidism/physiopathology , Male , Median Eminence/drug effects , Pituitary Gland/drug effects , Propylthiouracil/adverse effects , RNA, Messenger , Rats , Rats, Sprague-Dawley , Thyroid Gland/drug effects , Thyrotropin/biosynthesis , Thyroxine/adverse effects , Triiodothyronine/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...